Business Description
Alterity Therapeutics Ltd
ISIN : US7397272045
Description
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 75.11 | |||||
Equity-to-Asset | 0.84 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | N/A | |||||
Interest Coverage | N/A | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 26.3 | |||||
3-Year EPS without NRI Growth Rate | 26.3 | |||||
3-Year FCF Growth Rate | 10.1 | |||||
3-Year Book Growth Rate | 8.7 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 47.46 | |||||
9-Day RSI | 50.24 | |||||
14-Day RSI | 51.39 | |||||
6-1 Month Momentum % | -32.99 | |||||
12-1 Month Momentum % | -42.98 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 6.17 | |||||
Quick Ratio | 6.17 | |||||
Cash Ratio | 3.6 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -33 | |||||
Shareholder Yield % | -4.59 |
Profitability Rank
Name | Current | Vs Industry | Vs History |
---|
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 0.67 | |||||
Price-to-Tangible-Book | 0.6 | |||||
EV-to-EBIT | -1.11 | |||||
EV-to-EBITDA | -1.11 | |||||
EV-to-FCF | -1.93 | |||||
Earnings Yield (Greenblatt) % | -90.09 | |||||
FCF Yield % | -26.16 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Alterity Therapeutics Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | |||
EPS (TTM) (€) | -2.153 | ||
Beta | 1.33 | ||
Volatility % | 134.53 | ||
14-Day RSI | 51.39 | ||
14-Day ATR (€) | 0.206168 | ||
20-Day SMA (€) | 1.5915 | ||
12-1 Month Momentum % | -42.98 | ||
52-Week Range (€) | 0.965 - 3.8 | ||
Shares Outstanding (Mil) | 8.73 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 0 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Alterity Therapeutics Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Alterity Therapeutics Ltd Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Alterity Therapeutics Ltd Frequently Asked Questions
What is Alterity Therapeutics Ltd(STU:PBN0)'s stock price today?
When is next earnings date of Alterity Therapeutics Ltd(STU:PBN0)?
Does Alterity Therapeutics Ltd(STU:PBN0) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |